feed,title,long_url,short_url
Benzinga,AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter,https://benzinga.com/general/biotech/23/05/32554761/astrazeneca-spin-off-entasis-secures-fda-approval-for-first-pathogen-targeted-therapy-addressing-,https://da.gd/rXti
